The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Acces GIR
Login
Català
Castellano
English
The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Search
Most popular
COL·LABORA
Menu
English
Català
Español
Home
USR Costa de Ponent
USR Costa de Ponent
Presentation
Team
Groups
Publications
Projects
News
Presentation
Team
Groups
Publications
Projects
News
Projects
Group projects
Estudio multicéntrico, de seguridad y tolerabilidad a largo plazo con Rupatadina 10mg en el tratamiento de la rinitis alérgica perenne persistente moderada-severa (PAR) durante 12 meses
Principal investigators:
Jose Antonio Castillo Vizuete,
Code:
5A04/009
Start year:
2004
Estudio multicéntrico a largo plazo, post-tratamiento, de seguimiento de la seguridad en pacientes con diabetes mellitus tipo 2 procedentes de los ensayos GALLANT, GALLEX o ARMOR. G-PLUS (GALIDA – Post treatment Long-term follow-Up Study)
Principal investigators:
Rosa Viñas Vidal
Code:
5A05/018
Start year:
2005
Estudio de eficacia y seguridad del antihistaminico V0114CP 2,5 mg en el tratamiento de la rinitis alérgica perenne. Estudio aleatorizado, doble ciego, en tres grupos paralelos, incluyendo un grupo placebo y un grupo control activo (levocetirizina 5 mg).
Principal investigators:
Jose Antonio Castillo Vizuete,
Code:
5A07/022
Start year:
2007
24 – FIATE (SEMFYC)
Principal investigators:
Maria Jesus Gallardo Guerra
Code:
5OB-024
Start year:
2009
Ensayo clínico, aleatorizado, abierto, muticentrico, de grupos paralelos y con grupo control, para la evaluación del efecto de PAPILOCARE® en la normalización de las alteraciones citológicas del cuello del útero causadas por el VPH (Ensayo Clínico PALOMA II)
Principal investigators:
Blas Ruperez Perez
Code:
5A18/004
Start year:
2018
Anterior
1
…
70
71
72
73
74
…
81
Següent
Board of Trustees
Collaborators
Accreditations